HomeREGULATORY
REGULATORY

MHLW Panel Backs Approval for AZ’s Olaparib, Benralizumab and More
(Nov.28.2017)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on November 24 recommended approval for a batch of drugs including AstraZeneca’s oral PARP inhibitor olaparib ...
(LOG IN FOR FULL STORY)